Abbonarsi

Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial - 30/10/21

Doi : 10.1016/j.ahj.2021.08.009 
Harry Klimis, MBBS, FRACP, PhD a, b, , Aravinda Thiagalingam, MBChB, FRACP, FCSANZ, PhD a, b, Daniel McIntyre, BSc(MedSc) a, Simone Marschner, MSc a, Amy Von Huben, MBiostat a, Clara K. Chow, MBBS, FRACP, PhD a, b
a Westmead Applied Research Centre and Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia 
b Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia 

Reprint requests: Harry Klimis, MBBS, FRACP, PhD The University of Sydney, Faculty of Medicine and Health, Westmead Hospital Cardiology, Westmead Applied Research Centre, Level 6, Block K, Entrance 10, Hawkesbury Road, Westmead, NSW 2145, AustraliaHarry Klimis, MBBS, FRACP, PhD The University of Sydney, Faculty of Medicine and Health, Westmead Hospital Cardiology, Westmead Applied Research CentreLevel 6, Block K, Entrance 10, Hawkesbury Road, Westmead, NSW 2145Australia

Riassunto

Background

Primary prevention guidelines emphasize the importance of lifestyle modification, but many at high-risk have suboptimal cardiovascular risk factor (CVRF) control. Text message support may improve control, but the evidence is sparse. Our objective was to determine the impact of text messages on multiple CVRFs in a moderate-high risk primary prevention cohort.

Methods

This study was a single-blind randomized clinical trial comparing semi-personalized text message-based support to standard care. A random sample of adults with 10-year absolute cardiovascular risk score ≥10% and without coronary heart disease, referred from February 2019 to January 2020, were recruited from an outpatient cardiology clinic in a large tertiary hospital in Sydney, Australia. Patients were randomized 1:1 to intervention or control. Intervention participants received 4 texts per week over 6 months, and standard care, with content covering: diet, physical activity, smoking, general cardiovascular health, and medication adherence. Controls received standard care only. Content was semipersonalized (smoking status, vegetarian or not-vegetarian, physical ability, taking medications or not) and delivered randomly using automated software. The primary outcome was the difference in the proportion of patients who have ≥3 uncontrolled CVRFs (out of: low-density lipoprotein cholesterol >2.0 mmol/L, blood pressure >140/90 mm Hg, body mass index ≥25 kg/m2, physical inactivity, current smoker) at 6 months adjusted for baseline. Secondary outcomes included differences in biomedical and behavioral CVRFs.

Results

Among 295 eligible participants, 246 (mean age, 58.6 ± 10.7 years; 39.4% female) were randomized to intervention (n = 124) or control (n = 122). At 6 months, there was no significant difference in the proportion of patients with ≥3 uncontrolled CVRFs (adjusted relative risk [RR] 0.98; 95% confidence interval [CI] 0.75-1.29; P = .88). Intervention participants were less likely to be physically inactive (adjusted RR 0.72; 95% CI 0.57-0.92; P = .01), but there were no significant changes in other single CVRFs. More intervention participants reduced the number of uncontrolled CVRFs at 6-months from baseline than controls (86% vs 75%; RR 1.15; 95% CI 1.00-1.32; P = .04).

Conclusions

In moderate-high cardiovascular risk primary prevention, text message-based support did not significantly reduce the proportion of patients with ≥3 uncontrolled CVRFs. However, the program did motivate behavior change and significantly improved cardiovascular risk factor control overall. Larger multicenter studies are needed.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Clinical trial registration: anzctr.org.au Identifier: ACTRN12618001153202.


© 2021  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 242

P. 33-44 - Dicembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Sex-based difference in fractional flow reserve and its impact on clinical outcomes
  • Mohammad Alkhalil, Gavin Thomas, Mark S. Spence, Colum Owens, Peter McKavanagh
| Articolo seguente Articolo seguente
  • Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease
  • Nilay Kumar, Haolin Xu, Neetika Garg, Ambarish Pandey, Roland A Matsouaka, Michael E Field, Mintu P Turakhia, Jonathan P Piccini, William R Lewis, Gregg C Fonarow

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.